Search results
Jun 26, 2024 · After 33 years, Geron’s first approval marks a turn in Nobel-winning science The decades-long story of how a first-in-class blood cancer treatment went from bench to bedside. Published June 26, 2024
2 days ago · FDA reviewers seem unconvinced by Geron's data on myelodysplastic syndrome therapy imetelstat ahead of FDA adcomm meeting.
Jun 8, 2024 · Among the potential gero-electroceuticals are ivermectin, which targets glycine- and glutamate-gated chloride channels, and monensin, which acts as a sodium ionophore. These drugs restore regeneration.
Jun 8, 2024 · FDA approves Geron's Rytelo for low-risk MDS patients, but stiff competition and need for more capital suggest selling stock. See why GREN stock is sell rated.
Jun 17, 2024 · Gero - Developer of reverse engineering technology for controlling aging. Raised a total funding of $13.5M over 3 rounds from 10 investors. Founded by Peter Fedichev and Maxim Kholin in the year 2015. Gero has 206 competitors.
Jun 18, 2024 · Get Geron Corp (GERN.O) real-time stock quotes, news, price and financial information from Reuters to inform your trading and investments
4 days ago · The recent FDA approval of RYTELO™ (imetelstat) has propelled Geron Corporation NASDAQ: GERN into the spotlight, sparking a surge in Geron's stock price and attracting heightened attention from investors seeking opportunities within the healthcare sector and biotech sector.
